Quick Answer
IMMUCELL CORP /DE/ reported Total Assets of $42.53 million for fiscal year 2025.
IMMUCELL CORP /DE/ Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $42.53M | -5.7% |
| 2024 | $45.10M | +3.0% |
| 2023 | $43.81M | -2.3% |
| 2022 | $44.86M | +0.9% |
| 2021 | $44.47M | +10.2% |
| 2020 | $40.35M | +4.3% |
| 2019 | $38.69M | +18.2% |
| 2018 | $32.73M | -4.6% |
| 2017 | $34.30M | +38.9% |
| 2016 | $24.70M | +69.9% |
| 2015 | $14.54M | +31.6% |
| 2014 | $11.05M | +0.8% |
| 2013 | $10.96M | -0.6% |
| 2012 | $11.03M | +0.4% |
| 2011 | $10.99M | +2.2% |
| 2010 | $10.75M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $45.73M | +2.9% | -2.1% |
| June 30, 2025 | $46.72M | +11.6% | +2.4% |
| March 31, 2025 | $45.62M | +6.0% | +1.2% |
| December 31, 2024 | $45.10M | +3.0% | +1.5% |
| September 30, 2024 | $44.45M | -0.2% | +6.2% |
| June 30, 2024 | $41.86M | -4.9% | -2.8% |
| March 31, 2024 | $43.05M | -0.2% | -1.7% |
| December 31, 2023 | $43.81M | -2.3% | -1.7% |
- IMMUCELL CORP /DE/ showed a decrease of -5.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, IMMUCELL CORP /DE/’s total assets has grown by 295.6% (from $10.75 million to $42.53 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: